Vivek Jha's Avatar

Vivek Jha

@vjha.bsky.social

425 Followers  |  548 Following  |  28 Posts  |  Joined: 03.12.2024  |  1.9516

Latest posts by vjha.bsky.social on Bluesky

Post image

๐ŸŽ™๏ธ Check out the latest Global Kidney Care Podcast!

Winston Fung leads a discussion on how climate change is shaping kidney health ๐ŸŒŽ with Prof. @vjha.bsky.social, Maryvonne Hourmant, @sfndt.bsky.social Past president, and Letizia De Chiara.

globalkidneycarepodcast.transistor.fm/episodes/sea...

03.11.2025 17:33 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image Post image Post image Post image

Our Nutrition team took Indiaโ€™s voices to the global stage at 23rd IUNS International Congress of Nutrition in Paris. With 7 presentations, they showcased Indigenous food systems, dietary diversity, child feeding practices, food procurement, Indian adaptation of the Mediterranean diet & more. [1/2]

29.08.2025 08:13 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

๐Ÿ… Prof. Vivekanand Jha @vjha.bsky.socialโ€ฌ (India), winner of the Jean Hamburger Award lite.spr.ly/6000KvmY

26.08.2025 13:23 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Welcome EASi-KIDNEY is an international, multi-centre, randomised double-blind placebo-controlled trial to assess whether in addition to standard care, the drug vicadrostat reduces the risk of kidney disease ...

First randomization in India for EASi-KIDNEY!๐ŸŽ‰๐Ÿฅณ
Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support.

Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH

www.easikidney.org

23.08.2025 02:42 โ€” ๐Ÿ‘ 8    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

NOACs offer a practical solution for PMN patients at high risk of thrombosisโ€”less monitoring, fewer clinic visits, and good safety profile, even in low-resource settings. More research needed, but early results are encouraging! #KidneyHealth #Anticoagulation

27.06.2025 15:25 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
https://indianjnephrol.org/apixaban-in-primary-membranous-nephropathy-report-from-the-itangible-registry/

New study: NOACs like apixaban safe & effective for short-term prevention of blood clots in primary membranous nephropathy patients with low albuminโ€”no VTEs, low bleeding risk. Promising alternative to warfarin! #Nephrology #VTE #PatientCare t.co/mSt3nhKMvm @isn-india.bsky.social

27.06.2025 15:25 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Understand the journey from preclinical primate studies to human deceased donor (decedent) and living recipient transplants, and the ethical, social, regulatory, and practical implications of this technology, including its potential for scalability, cost, relevance to children.

27.06.2025 14:32 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
https://youtu.be/pbumiUjck1I?si=CShZCu48Gw3Ws84Z

Listen to Dr Vasistha Tatapudi of from focusing on the use of pig kidneys in humans - the rationale, immunological challenges, and genetic modifications involved in overcoming hyperacute rejection. t.co/Htzs11a711

27.06.2025 14:32 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Nice case and good discussion on how to interpret clinical clues

27.06.2025 00:25 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Case Presentations in Nephrology - An Indian Society of Nephrology Initiative
YouTube Recording ๐Ÿ‘‰ m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)

25.06.2025 11:32 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1

Cholecalciferol supplementation significantly improved vascular function (flow-mediated dilation) in CKD patients,

Changes in immune and vascular function were not directly linked. Findings support vitamin Dโ€™s role in immune and vascular health in CKD.

24.04.2025 13:26 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Secondary analysis of RCT of High-dose cholecalciferol (vitamin D3) in non-diabetic #CKD patients. #Vit D
โžก๏ธ shifted immune balance toward anti-inflammatory TH2 cells,
โžก๏ธ โฌ‡๏ธ pro-inflammatory cytokines, โฌ†๏ธ vitD-responsive gene expression
โžก๏ธ showing direct immune modulation benefits CKD. #Immunology

24.04.2025 13:25 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Frontiers | Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease

Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease
frontiersin.org/journals/imm...
@vjha.bsky.social

24.04.2025 06:00 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Congratulations to Dr Jha and the team! Collaboration and data sharing is the way forward! ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ–๏ธ

21.03.2025 23:17 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

โžก๏ธ establishes platform for studying disease course, treatment patterns, and outcomes of GNs in India
โžก๏ธ with consent for contact regarding clinical trials and biobanking, offers recruitment potential 4 studies investigating emerging therapies
โžก๏ธ Collaboration with established international registries

20.03.2025 02:36 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Decoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE Registry Glomerular diseases are a leading cause of kidney disease worldwide, especially in low-and middle-income countries. At the global level, collaborative initiatives have been started to provide informat...

Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India.

โžก๏ธ The first such cohort in the developing (majority) world
โžก๏ธ Will help understand disease phenotypes in the Indian context

Funded by #ICMR

www.kireports.org/article/S246...

20.03.2025 02:36 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1
World Kidney Day logo and this year's campaign, Are your Kidneys OK campaign logo

World Kidney Day logo and this year's campaign, Are your Kidneys OK campaign logo

Happy 20th anniversary #WorldKidneyDay ๐ŸŽ‰
Two decades of successful awareness campaigns!

On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening.

13.03.2025 09:42 โ€” ๐Ÿ‘ 11    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image Post image

Remembering Bill Couser who we lost recently on this #WKD for his huge contributions to conceiving this initiative that has made such a difference to kidney health awareness around the world @theisn.org

www.kidney-international.org/article/S008...

13.03.2025 12:03 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Video thumbnail

๐ŸŒŽAre your kidneys OK? ยฟTus riรฑones estรกn bien? Vos reins vont bien? ู‡ู„ ูƒู„ูŠุชูŠูƒ ุจุฎูŠุฑุŸ ; เค†เคชเค•เฅ€ เค•เคฟเคกเคจเฅ€ เค เฅ€เค• เคนเฅˆ? Os seus rins estรฃo bem? @theisn.org @drpriyajohn.bsky.social @nephromythri.bsky.social @sabinekaram.bsky.social

#WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky

13.03.2025 03:35 โ€” ๐Ÿ‘ 3    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

#WorldKidneyDay Rally in #Bangladesh.

13.03.2025 03:46 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Thanks @roy-chaudhury.bsky.social and tons of colleagues from all around the world for making the Congress such a success - #WCN was really special with its theme of equity, sustainability and accountability

10.03.2025 09:58 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Congratulations Vivek on the broad swathe of holistic science presented at WCN in New Delhi. It was an outstanding meeting!
@vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social

17.02.2025 19:42 โ€” ๐Ÿ‘ 4    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Video thumbnail

@vjha.bsky.social welcoming the audience to India and #ISNWCN

06.02.2025 11:55 โ€” ๐Ÿ‘ 4    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

"Decoding Glomerulonephritis: Baseline Profiles and Insights from the I-TANGIBLE Registry" by Kavita Yadav, @vjha.bsky.social et al.

๐Ÿ”— Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN

07.02.2025 13:01 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

First steps in efforts to characterise the burden of CKDu across different regions. Fantastic work led by Charlotte in collaboration with so many brilliant investigators from around the world.

If we understand where it is, maybe we can understand what it is.

with @vjha.bsky.social and others

16.01.2025 12:00 โ€” ๐Ÿ‘ 4    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

The @natureportfolio.bsky.social Access to Dialysis in Low and Middle-Income Countries Commission will explore Thailandโ€™s experiences with changing its dialysis coverage policy, offering lessons for other countries with universal health coverage systems

@theisn.org @who.int @hitap.bsky.social

28.01.2025 10:34 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿฉบ Universal Health Coverage in Action

Thailandโ€™s PD-first policy proved dialysis can be affordable in LMICs, but its reversal raises questions about equity and sustainability. Can lessons from Thailand guide better UHC policies globally? #KidneyCare #SustainableHealthcare

28.01.2025 10:34 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

๐Ÿ’ก Policy Change & Impact

The abrupt dialysis policy shift in 2022 highlights the risks of untested reforms. The new commission aims to assess impacts and create evidence-based recommendations for sustainable dialysis care in LMICs. #HealthPolicy #DialysisCare

28.01.2025 10:34 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

๐ŸŒ Dialysis in LMICs: A Lesson from Thailand

Thailandโ€™s PD-first policy (2008-2022) transformed dialysis care, saving lives and reducing poverty. But a 2022 shift to patient choice revealed unintended consequences. Lessons for universal health coverage worldwide. #UHC #GlobalHealth

28.01.2025 10:34 โ€” ๐Ÿ‘ 4    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
2024 โ€“ A Year in Review - Indian Journal of Nephrology [article]

Good noon all,

IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.

Kindly follow the link: indianjnephrol.org/current-issue/

@arvindcanchi.bsky.social @priti899.bsky.social

04.01.2025 11:37 โ€” ๐Ÿ‘ 13    ๐Ÿ” 6    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

@vjha is following 19 prominent accounts